UNSPSC 85882817: Tomographic (tomo) nuclear medicine imaging of abdomen using other radionuclide

This classification denotes the group of activities that yields an intervention or procedure of tomographic (tomo) nuclear medicine imaging of abdomen using other radionuclide. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code CW20YZZ

UNSPSC 85882817 Tomographic (tomo) nuclear medicine imaging of abdomen using other radionuclide is a Commodity code that nominally describes a specific radiopharmaceutical imaging modality, but the recent state and local contract opportunities posted under this code do not align with the code's technical scope. The three most recent opportunities—a diagnostic imaging PACS implementation at San Mateo Medical Center, special education contracted services at Birdville Independent School District, and a temporary health professional staffing vehicle at Santa Clara County Health System—represent IT infrastructure procurement, educational support services, and general health workforce staffing respectively. None involve tomographic nuclear medicine imaging of the abdomen or any radiopharmaceutical imaging service. This code shows little relevant recent activity for vendors seeking to pursue state and local contracts in nuclear medicine imaging or related diagnostic imaging products and services.

The mismatch between the code's nominal definition and the work actually tagged in recent solicitations suggests either a classification error in the source records or a code applied inconsistently across issuing bodies. Prospective vendors should verify code assignments with individual procurement offices before submitting proposals and consider whether their actual service or product offerings align with the posted opportunity scope rather than the UNSPSC code name alone. Without a pattern of properly aligned recent opportunities under this code, there is no actionable geographic concentration, issuing-body profile, or representative procurement activity to guide business development strategy at this time.